scholarly journals Cardiovascular effects of sulphonylurea derivatives

Diabetologia ◽  
1997 ◽  
Vol 40 (0) ◽  
pp. S160-S161 ◽  
Author(s):  
P. Smits
Keyword(s):  
Cardiovascular Effects ◽  
Sulphonylurea Derivatives

scholarly journals Cardiovascular effects of sulphonylurea derivatives

Diabetologia ◽  
1995 ◽  
Vol 38 (1) ◽  
pp. 116-121 ◽  
Author(s):  
P. Smits ◽  
T. Thien
Keyword(s):  
Cardiovascular Effects ◽  
Sulphonylurea Derivatives

scholarly journals Cardiovascular effects of sulphonylurea derivatives

1996 ◽  
Vol 31 ◽  
pp. S55-S59 ◽  
Author(s):  
Paul Smits ◽  
Peter J. Bijlstra ◽  
Frans G.M. Russel ◽  
Jos A. Lutterman ◽  
Theo Thien
Keyword(s):  
Cardiovascular Effects ◽  
Sulphonylurea Derivatives

Cannabis-associated arteritis

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen
Keyword(s):  
Systematic Review ◽  
Case Reports ◽  
Case Series ◽  
Cardiovascular Effects ◽  
Causative Factor ◽  
Cannabis Use ◽  
Thromboangiitis Obliterans ◽  
Pathological Features ◽  
Scientific Support ◽  
Clinical And Pathological Features

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.

Some cardiovascular effects of the aqueous extract of the leaves of Starchytarpheta jamaicensis L. (Vahl)

Planta Medica ◽  
2006 ◽  
Vol 72 (11) ◽  
Author(s):  
M Idu ◽  
EKI Omogbai ◽  
F Amaechina ◽  
JE Ataman
Keyword(s):  
Aqueous Extract ◽  
Cardiovascular Effects

Cardiovascular effects of treatment with Liraglutide in a population with type 2 diabetes

2013 ◽  
Author(s):  
Marco Zavattaro ◽  
Flavia Prodam ◽  
Mauri Maria Grazia ◽  
Loredana Pagano ◽  
Marina Caputo ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Effects

Sulphonylurea derivatives are still efficacious in daily anti-diabetes clinical practice

2018 ◽  
Vol 11 (1) ◽  
pp. 25-30
Author(s):  
Dorota Kuzemko-Baranowska ◽  
Piotr Gajda ◽  
Grzegorz Dzida
Keyword(s):  
Clinical Practice ◽  
Sulphonylurea Derivatives
Sign in / Sign up

Export Citation Format

Share Document